Unmet needs in atopic dermatitis management: an expert consensus.


Journal

The Journal of dermatological treatment
ISSN: 1471-1753
Titre abrégé: J Dermatolog Treat
Pays: England
ID NLM: 8918133

Informations de publication

Date de publication:
Aug 2022
Historique:
pubmed: 28 8 2021
medline: 16 8 2022
entrez: 27 8 2021
Statut: ppublish

Résumé

Atopic dermatitis (AD) has substantial negative impact on patients' quality of life. Although considerable advances have been made in understanding the pathogenesis and its treatment, there is still limited transfer of this knowledge into daily management. Aiming to identify unmet needs in clinical management of patients with AD, we used a Delphi consensus process. A set of statements regarding diagnosis, management, prognosis, and treatment was identified by five experts (Steering Committee). Then, the Steering Committee and a second group of four clinicians were involved in a Delphi process. Lastly, agreement was assessed in a larger panel of Italian clinicians. Overall, 37 clinicians participated to the process. 17 statements reached strong agreement and 2 reached weak agreement. In general, the statements reflected the need for accurate and effective diagnostic criteria to support clinical experience, especially in the atypical forms of AD. Moreover, prognostic criteria are needed to predict the duration of adult-onset AD. The identification of biomarkers was considered to be useful for clinical management of AD at all stages of disease. Lastly, greater emphasis should be placed on patient education and development of effective tools that can aid informing patients about their disease and its treatment.

Identifiants

pubmed: 34445932
doi: 10.1080/09546634.2021.1967267
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2459-2465

Auteurs

Annalisa Patrizi (A)

Dermatology, IRCCS S. Orsola-Malpighi Polyclinic, Bologna, Italy.
Department of Specialistic, Diagnostic and Experimental Medicine (DIMES), Alma Mater Studiorum University of Bologna, Bologna, Italy.

Antonio Costanzo (A)

Dermatology, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.

Cataldo Patruno (C)

Dermatology Unit, Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy.

Valentina Maria Busà (VM)

Medical Department, Inflammation and Immunology, Pfizer, Italy.

Andrea Chiricozzi (A)

Dermatology, Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Dermatology, Department of Clinical and Translational Medicine, Università Cattolica del Sacro Cuore, Rome, Italy.

Giampiero Girolomoni (G)

Department of Medicine, Section of Dermatology, University of Verona, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH